NFKB1 and cancer: In addition, diosmin has been shown to inhibit cancer cell proliferation, migration, and invasion by regulating various signaling pathways, including the PI3K/Akt/mTOR pathway, the MAPK/ERK pathway, and the NF‐κB pathway.